Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 0 Bladder Cancer”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Testing effectiveness (Phase 2)Study completedNCT00088946
What this trial is testing

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
Jonsson Comprehensive Cancer Center 17
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Large-scale testing (Phase 3)UnknownNCT00553124
What this trial is testing

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital Birmingham 3,400
Testing effectiveness (Phase 2)Study completedNCT00023842
What this trial is testing

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 97
Testing effectiveness (Phase 2)Study completedNCT00002917
What this trial is testing

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Large-scale testing (Phase 3)UnknownNCT00003725
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals 300
Very early researchEnded earlyNCT01245660
What this trial is testing

Of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy

Who this might be right for
Bladder CarcinomaInfiltrative Bladder CarcinomaCystectomy
University Hospital, Bordeaux 3
Not applicableUnknownNCT00553566
What this trial is testing

Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
University of Birmingham 1,600
Testing effectiveness (Phase 2)Study completedNCT00234039
What this trial is testing

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 58
Large-scale testing (Phase 3)Study completedNCT00729287
What this trial is testing

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
KU Leuven 276
Early research (Phase 1)WithdrawnNCT03552796
What this trial is testing

SEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaBladder Cancer Stage 0Bladder Cancer Stage I
University of Southern California
Very early researchEnded earlyNCT01261299
What this trial is testing

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungUrinary Bladder Neoplasms
University of California, Davis 21
Not applicableUnknownNCT00553215
What this trial is testing

Quality of Life in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
University of Birmingham 2,700
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Very early researchStudy completedNCT01827618
What this trial is testing

Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

Who this might be right for
Invasive Bladder Cancer Stage II
The University of Texas Health Science Center at San Antonio 29
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)UnknownNCT00553345
What this trial is testing

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
University of Birmingham 515
Large-scale testing (Phase 3)Ended earlyNCT00042887
What this trial is testing

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 58
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Early research (Phase 1)WithdrawnNCT00014287
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Who this might be right for
Bladder Cancer
University of Pittsburgh
Next Page